News
RO7589831, a new drug from Roche, is first in a new class of drugs called Werner helicase inhibitors. Drug works similarly to ...
New research led by the University of Sydney has revealed the potential of engineered proteins to more precisely deliver drugs within the body. The proof-of-concept research could potentially pave ...
New research led by the University of Sydney has revealed the potential of engineered proteins to more precisely deliver ...
A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current inflammatory bowel disease treatments. The proof-of-concept study, published ...
Hosted on MSN20d
Proof-of-concept study demonstrates targeted new approach to treat pancreatic cancer"Transcription-replication conflicts are an important vulnerability of pancreatic cancer," said Dr. Raoof, senior author of the new study. "Our study is the first to confirm proof of concept for ...
Faeth Therapeutics, a clinical-stage biotechnology company integrating precision nutrition with combination therapies to ...
This new technique, called GlycoCaging, allows powerful medicines to reach the inflamed part of the gut using much lower ...
A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current inflammatory bowel disease treatments. The proof-of-concept study introduced a ...
"With this technique, we have the ability to deliver not just steroids, but a range of drugs including antimicrobial ...
Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...
Unresolved Treatment Needs in IPF. Idiopathic Pulmonary Fibrosis (IPF) is a progressive, irreversible, and fatal interstitial lung disease characterized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results